Logo

CTCs

Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium

The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data.

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

The company is planning to develop circulating tumor cell assays for prostate cancer and acute myeloid leukemia and to launch them in the US.

Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights
Premium

The company is embarking on its own diagnostic plans as it prepares to market its platform for external test development following FDA clearance.

Datar Cancer Genetics Expands Business from Treatment Monitoring to Dx and Screening
Premium

The Indian liquid biopsy company recently launched its Trublood tests for prostate cancer and pan-cancer detection using circulating tumor cells.

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies

The companies are conducting a study to evaluate their combined platforms for the detection and characterization of CTCs in prostate cancer.

Jul 21, 2021

Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests

May 27, 2021

TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research
Premium

May 10, 2021

TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform

Mar 31, 2021

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

Mar 31, 2021

Startup MiCareo Targets Rare Cell Isolation Market With Flow Displacement Instrument
Premium

Mar 29, 2021

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

Mar 25, 2021

Startup Tethis Targets Early-Stage Breast Cancer Detection With CTC Sample Prep Platform
Premium

Mar 24, 2021

Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform

Mar 23, 2021

CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test

Mar 18, 2021

Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow

Mar 17, 2021

Metabolic Marker Helps Identify Lung Cancer-Linked Circulating Tumor Cells
Premium

Mar 3, 2021

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy
Premium

Jan 21, 2021

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay
Premium

Dec 18, 2020

BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership

Dec 10, 2020

Menarini's CellSearch Shows CTCs' Potential to Predict Breast Cancer Prognosis, Treatment Response
Premium

Nov 19, 2020

Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research

Nov 13, 2020

Biocept Eyes Neuro-Oncology for Future Liquid Biopsy Growth as Testing Lags Amid COVID Pandemic
Premium

Nov 9, 2020

Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform
Premium

Oct 29, 2020

Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Oct 9, 2020

Georgetown Team Sees Potential for Novel CTC Culture Method to Study Metastatic Cancer
Premium

Breaking News
The Scan

Monkeypox Case Found in US

The New York Times says that a case of monkeypox has now been reported in the US.

Effects on Fetal Screening

Wired writes that changes to US abortion laws could affect screening for fatal congenital conditions.

'Pharma Bro' Out of Prison

The Wall Street Journal reports that Martin Shkreli has been released from prison to a halfway house.

Nature Papers Present Cultivate Oat Genome, Benchmarking of Spatial and Single-Cell Transcriptomic Integration Methods

In Nature this week: reference genome of the cultivated oat, and more.